A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is vaginal delivery or caesarean section (CS) the safer mode of delivery in patients with adult congenital heart disease? Of the 119 studies, 13 papers represented the best evidence on the topic. Recommendations are based on 29 262 patients. Those having undergone successful corrective or palliative cardiac surgery for congenital heart disease, in addition to patients with unoperated congenital heart disease are a high-risk obstetric population. Heart disease is a leading cause of maternal mortality in the USA and the UK. Traditionally, CS was regarded as the mode of delivery of choice for high-risk patients, but growing experience in this field has now made this advice appear controversial. Patients are stratified into high-and low-risk, depending on the degree of heart failure symptoms [New York Heart Association (NYHA) class]. All studies demonstrated adverse outcomes in ACHD patients compared with normal age-matched controls. This pertained to a higher overall risk of maternal cardiac death, neonatal death, preterm birth, fetal growth restriction and longer hospital stay. On univariate regression analysis, the variables that imparted the highest risk to mother and foetus, were right ventricular failure, pulmonary regurgitation and pulmonary hypertension (P < 0.001). Induction of labour was deemed safe and was not associated with higher CS rates. There was no increase in maternal or neonatal complications in patients who were NYHA class I and II at labour. Patients who were NYHA class III and IV at labour had higher complication rates with adverse feto-maternal outcomes (P < 0.0001) and longer intensive care unit and hospital stay (Spearman's correlation 0.326, P = 0.007). The largest cohort from the USA (26 973 ACHD births) demonstrated that ventricular septal defect was associated with the highest risk of maternal death and complications (P < 0.05). The data would indicate that patients NYHA class I and II symptoms are suitable for VD. For most NYHA III and IV patients a trail of labour is safe with expedited delivery under good analgesic control as dictated by obstetric needs. Due to high complication risks, CS may be indicated in a proportion of patients.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in ICVTS [1] .
THREE-PART QUESTION

In which patients with [adult congenital heart disease] is [vaginal delivery] safer compared to a [caesarean section (CS)]?
CLINICAL SCENARIO
A 35-year old nulliparous woman wishes to start a family. She had an operation when she was a baby to correct a ventricular septal defect (VSD). She has been well since her operation. She is not on any medication. She has normal exercise tolerance. She is keen to have a pregnancy and normal delivery. She asks for your opinion, as to whether her heart is likely to tolerate the stress of labour and normal delivery. Non-ACHD CS rate 23% [2] CS rate
Maternal mortality
Neonatal death
Heart failure Prematurity NYHA I 76%, II 21%, III 1.3% and IV 1.5%
CS rate 38% (P < 0.001) Maternal mortality 0.5 vs 0.007% (P < 0.001)
Neonatal death 0.6 vs 0.4% (P < 0.001)
Heart failure 8 vs 0% (P < 0.001) Preterm birth 13 vs 8% (P < 0.001) NYHA >II or cyanosis (OR 6, P < 0.03); arrhythmia (OR 6, P < 0.001); poor LVEF (OR 11, P < 0.001); left heart obstruction (OR 6 P < 0.001) Independent risk factors of adverse neonatal outcome:
NYHA >II or cyanosis (OR 3, P < 0.03); left heart obstruction (OR 2 P < 0.04); heparin/warfarin (OR 3 P < 0.0093) Primary outcomes of interest were safe mode of delivery and mortality rates. Secondary outcomes of interest were instrumental delivery rates, CS rates, adverse maternal cardiac event and neonatal death.
RESULTS
Roos-Hesselink et al. [2] showed significantly higher maternal and neonatal mortality in ACHD compared with the normal population. The CS rate (38%) was significantly higher in ACHD (P < 0.001). ACHD had better outcomes compared with cardiomyopathy and valvular and ischaemic heart disease. A Canadian prospective multicentre registry consisting of 74% ACHD patients [New York Heart Association (NYHA) I/II 96%] [3] had a CS rate in ACHD patients similar to the background population. Independent risk factors identified for adverse maternal outcomes were NYHA > II or cyanosis (OR 6, P = 0.009); arrhythmia (OR 6, P < 0.001, poor left ventricular ejection fraction (OR 11, P < 0.001); left heart obstruction (OR 6 P < 0.001).
Karamlou et al. [4] reported 26 973 ACHD births. ACHD had a significantly higher rate of CS and overall maternal and neonatal morbidity and mortality, compared with age-matched controls. Diagnoses include: VSD (n = 4152, 15%); aortic valve pathology (n = 3412, 12.7%); ostium secundum atrial septal defect (ASD) (n = 3402, 12.6%). VSD was associated with the highest risk of maternal death and complications (P < 0.05).
Hidano et al. [5] reported 7-year outcomes in 151 births in ACHD patients. The series consisted of NYHA I/II, and severe lesions were delivered electively by CS. The CS rate in ACHD was significantly higher than the national average, of which 25% were done under general anaesthetic. Most complications occurred in the CS group (13% after VD and 37% after CS). Most of these adverse outcomes occurred in the elective caesarean group (35% maternal cardiac and 65% neonatal complications), done for maternal cardiac indications; this may also relate to a coexisting higher rate of foetal prematurity. Goldszmith et al. [6] found a comparable CS and complication rates for all NYHA (97% NYHA I and II) severities undergoing labour. General anaesthetic was associated with prematurity and multiple births in the presence of complex congenital heart disease. Caesarean section, epidural and general anaesthesia rates are similar to those in the general obstetric population.
Ouyang et al. [7] examined the effect of avoiding the Valsalva manoeuvre, as this is a commonly given suggestion for ACHD. Valsalva was cardiovascularly safe. The routine practice of avoiding valsalva is associated with significantly longer second stage (P = 0.075) with higher rates of PPH (P = 0.017) and third/fourth degree tears (P = 0.027).
Curtis et al. [8] reviewed 101 patients, 93% NYHA I. In 3%, the defects became apparent during pregnancy. Outcomes in NYHA I/II were better compared with NYHA III/IV, (P < 0.0001). VD was the commonest mode of delivery even in NYHA class III/IV and was safe, with an overall CS rate 29% [8] .
Wasim et al. [9] reported on 160 patients with heterogeneous cardiac lesions, including 28 ACHD patients. They had a large high-risk group (57% NYHA I/II and 43% NYHA III/IV), with a mortality of 3.8%. NYHA III and IV were the key determinants of adverse feto-maternal outcome (P < 0.0001).
Meng et al. found that increasing severity of pulmonary hypertension was associated with increasing preterm labour (7 vs 37.5%) [10] . There was no maternal mortality in NYHA I/II and mild to moderate pulmonary hypertension. All mortalities (4%) occurred in NYHA III/IV with severe pulmonary hypertension [10] . On univariate risk scoring history of CCF (odds ratio (OR) 15.5), NYHA ≥2 (OR 5.4), decreased right ventricle (RV) ejection fraction (OR 7.7) predicts poor outcomes. Independent predictors were decreased RV ejection fraction and/or severe pulmonary regurgitation (OR 9.0). In the presence of these variables, elective CS might be indicated.
Sadlik et al. [11] had a 13% CS rate that is comparable with the national average of 19%. They found ACHD to be an independent risk factor for neonatal malformations of 34/67 (50.7%). There were no differences in outcomes between mode of delivery for ACHD patients.
Khairy et al. [12] reported 90 pregnancies with univariate predictors of outcome being NYHA class >2 (OR 5.4) and decreased LV function (OR 7.7). Sixty-three percent of VD required instrumentation. 23.6% were CS and 76.4% VD, mode of delivery did not affect outcomes. Patients with impaired right ventricular function and severe pulmonary regurgitation had significantly poor outcomes.
Boyle et al. [13] reviewed 48 ACHD patients (70% NYHA III/IV) all of whom were offered vaginal birth. There were two maternal mortalities (2.5%). NYHA III/IV had a significantly larger number of ICU/CCU admissions (29.3%), vs 3.6% in the mild group (P < 0.05). Cardiac compromise occurred most during labour (n = 73), followed by the antenatal period (n = 2), the first week post-partum (1 patient), and 6 months after birth (n = 2). They had a CS rate of 28 vs 31% for the background population, when no elective caesareans were done for maternal cardiac indications.
McFaul et al. [14] reported outcomes over 13 years in 161 patients, recapitulating the finding that patients with NYHA III/IV symptoms accounted for all maternal deaths and a high incidence of perinatal complications. NYHA I/II could be safely delivered using VD.
CS is associated with higher blood loss, blood transfusion and greater overall fluctuations in haemodynamic status [15] . The patient has to be able to lie flat for at least 1 h during the procedure, which may not be possible in those with orthopnoea (NYHA III and IV). In centres where CS was only done for obstetric indications, i.e. with a CS rate similar to the background population, there was no significant difference in adverse outcomes between vaginal birth and CS [6, 11, 12] . Maternal outcomes are significantly affected by the nature of the cardiac lesion, and not by the mode of delivery [3, 4, 12] . Where possible, high-risk patients (such as NYHA III/IV, cyanosis, arrhythmia, heart failure, myocardial dysfunction, decreased RV ejection fraction, severe pulmonary valve regurgitation, subaortic ventricular outflow tract gradient >30 mmHg, VSD) should be identified and optimized prenatally [3, 4, 12] . Cardiac complications can occur at any time during pregnancy, birth or even up to 6 months after birth [13] .
CLINICAL BOTTOM LINE
Vaginal birth is safe in patients with ACHD of all severities, and a higher CS rate does not translate into improved outcomes. The evidence suggests that a higher CS rate is in fact associated with an increased overall risk of adverse outcomes (including mortality) for the mother. Perinatal complications and maternal mortality are associated with NYHA III/IV symptoms. ACHD patients should be managed in a tertiary centre due to the potential high risk of adverse maternal and neonatal outcomes.
